Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Brilinta significantly reduced rate of composite of stroke and death in THALES trial

pharmaceutical-business-reviewJuly 21, 2020

Tag: THALES , Brilinta , aspirin , stroke , TIA

PharmaSources Customer Service